Lawler J - Search Results

1

Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.

Desai P, Helkin A, Odugbesi A, Stein J, Bruch D, Lawler J, Maier KG, Gahtan V. Desai P, et al. Among authors: lawler j. J Surg Res. 2017 Apr;210:1-7. doi: 10.1016/j.jss.2016.10.007. Epub 2016 Oct 14. J Surg Res. 2017. PMID: 28457315

2

Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated.

Seymour KA, Sadowitz B, Stein JJ, Lawler J, Maier KG, Gahtan V. Seymour KA, et al. Among authors: lawler j. Am J Surg. 2011 Nov;202(5):553-7. doi: 10.1016/j.amjsurg.2011.06.025. Epub 2011 Sep 9. Am J Surg. 2011. PMID: 21906719

3

Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: the role of the type 3 repeat and carboxyl terminal domains.

Lee T, Nesselroth SM, Olson ET, Esemuede N, Lawler J, Sumpio BE, Gahtan V. Lee T, et al. Among authors: lawler j. J Cell Biochem. 2003 Jun 1;89(3):500-6. doi: 10.1002/jcb.10524. J Cell Biochem. 2003. PMID: 12761883

4

The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis.

Nesselroth SM, Willis AI, Fuse S, Olson ET, Lawler J, Sumpio BE, Gahtan V. Nesselroth SM, et al. Among authors: lawler j. J Vasc Surg. 2001 Mar;33(3):595-600. doi: 10.1067/mva.2001.112318. J Vasc Surg. 2001. PMID: 11241132 Free article.

5

Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.

Hamano Y, Sugimoto H, Soubasakos MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R. Hamano Y, et al. Among authors: lawler j. Cancer Res. 2004 Mar 1;64(5):1570-4. doi: 10.1158/0008-5472.can-03-3126. Cancer Res. 2004. PMID: 14996710

6

Thrombospondin-1-Based Antiangiogenic Therapy.

Sims JN, Lawler J. Sims JN, et al. Among authors: lawler j. J Ocul Pharmacol Ther. 2015 Sep;31(7):366-70. doi: 10.1089/jop.2015.0018. Epub 2015 Jun 3. J Ocul Pharmacol Ther. 2015. PMID: 26352160 Free PMC article.

7

Regulation of tumor angiogenesis by thrombospondin-1.

Ren B, Yee KO, Lawler J, Khosravi-Far R. Ren B, et al. Among authors: lawler j. Biochim Biophys Acta. 2006 Apr;1765(2):178-88. doi: 10.1016/j.bbcan.2005.11.002. Epub 2005 Dec 21. Biochim Biophys Acta. 2006. PMID: 16406676 Review.

8

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

Ren B, Song K, Parangi S, Jin T, Ye M, Humphreys R, Duquette M, Zhang X, Benhaga N, Lawler J, Khosravi-Far R. Ren B, et al. Among authors: lawler j. Cancer Res. 2009 May 1;69(9):3856-65. doi: 10.1158/0008-5472.CAN-08-2940. Epub 2009 Apr 14. Cancer Res. 2009. PMID: 19366809 Free PMC article.

9

Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.

Zhang X, Galardi E, Duquette M, Delic M, Lawler J, Parangi S. Zhang X, et al. Among authors: lawler j. Clin Cancer Res. 2005 Mar 15;11(6):2337-44. doi: 10.1158/1078-0432.CCR-04-1900. Clin Cancer Res. 2005. PMID: 15788685

10

Thrombospondin-1 plays a critical role in the induction of hair follicle involution and vascular regression during the catagen phase.

Yano K, Brown LF, Lawler J, Miyakawa T, Detmar M. Yano K, et al. Among authors: lawler j. J Invest Dermatol. 2003 Jan;120(1):14-9. doi: 10.1046/j.1523-1747.2003.12045.x. J Invest Dermatol. 2003. PMID: 12535193 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters